v3.26.1
Statements of Changes in Capital Deficiency - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
BALANCE AT DECEMBER 31, 2024 $ (2,069,000) $ (5,470,000)
Sponsor loan waiver   860,000
Valuation of promissory note   246,000
Sponsor surrender of founder shares 347,000 277,000
Sponsor assignment of stock based compensation   387,000
Accretion of Class A common stock subject to redemption amount (684,000) (1,485,000)
Underwriters’ deferred compensation waiver   4,428,000
Net loss for the year (559,000) (1,312,000)
BALANCE AT DECEMBER 31, 2025 (2,965,000) (2,069,000)
Common Stock [Member] | Common Class A [Member]    
BALANCE AT DECEMBER 31, 2024
BALANCE, SHARES 3,162,499 3,162,499
Net loss for the year
BALANCE AT DECEMBER 31, 2025
BALANCE, SHARES 3,162,499 3,162,499
Common Stock [Member] | Common Class B [Member]    
BALANCE AT DECEMBER 31, 2024
BALANCE, SHARES 1 1
Net loss for the year
BALANCE AT DECEMBER 31, 2025
BALANCE, SHARES 1 1
Additional Paid-in Capital [Member]    
BALANCE AT DECEMBER 31, 2024 $ 285,000
Sponsor loan waiver   860,000
Valuation of promissory note   246,000
Sponsor surrender of founder shares 347,000 277,000
Sponsor assignment of stock based compensation   387,000
Accretion of Class A common stock subject to redemption amount (632,000) (1,485,000)
Net loss for the year
BALANCE AT DECEMBER 31, 2025 285,000
Retained Earnings [Member]    
BALANCE AT DECEMBER 31, 2024 (2,354,000) (5,470,000)
Accretion of Class A common stock subject to redemption amount (52,000)  
Underwriters’ deferred compensation waiver   4,428,000
Net loss for the year (559,000) (1,312,000)
BALANCE AT DECEMBER 31, 2025 $ (2,965,000) $ (2,354,000)